Medicare Enrolled
Dr. Savitha Kadakol, MD
Hematology & Oncology · Sterling Heights, MI
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kadakol from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kadakol?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kadakol
Dr. Savitha Kadakol is a hematology & oncology specialist in Sterling Heights, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kadakol performed 79,860 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Kadakol received a total of $17,960 from 80 pharmaceutical and/or device companies across 1016 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kadakol is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 7% volume in MI
$17,960 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗79,860
Medicare services
Top 7% in MI for hematology & oncology
Not available
Unique patients (not deduplicated)
$2
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
77,010 | $0 | $2 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,020 | $7 | $18 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
715 | $93 | $187 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
259 | $11 | $33 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
192 | $62 | $123 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
156 | $50 | $140 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
90 | $18 | $45 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
82 | $1 | $15 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
80 | $125 | $242 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
78 | $70 | $119 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
58 | $102 | $194 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
38 | $26 | $88 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
36 | $1 | $10 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
24 | $143 | $209 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
22 | $4 | $4 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
96.7% high complexity
0.4% medium
2.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$17,960
Total received (2018-2024)
Avg $2,566/year across 7 years
Top 10% in MI for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
80
Companies
1,016
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,059
2023
$2,960
2022
$3,146
2021
$2,975
2020
$1,437
2019
$2,056
2018
$2,328
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$263
Merck Sharp & Dohme LLC
$194
Daiichi Sankyo Inc.
$166
GENZYME CORPORATION
$164
ABBVIE INC.
$152
Genentech USA, Inc.
$143
Lilly USA, LLC
$119
PFIZER INC.
$119
Novartis Pharmaceuticals Corporation
$103
Eisai Inc.
$103
Incyte Corporation
$102
Takeda Pharmaceuticals U.S.A., Inc.
$100
Celgene Corporation
$99
Gilead Sciences, Inc.
$94
Janssen Biotech, Inc.
$86
E.R. Squibb & Sons, L.L.C.
$76
JAZZ PHARMACEUTICALS INC.
$73
TAIHO ONCOLOGY, INC.
$72
Exelixis Inc.
$69
Agios Pharmaceuticals, Inc.
$68
SOBI, INC
$64
Stemline Therapeutics Inc.
$63
Astellas Pharma US Inc
$62
BeiGene USA, Inc.
$57
Karyopharm Therapeutics Inc.
$57
Pharmacosmos Therapeutics Inc.
$49
Kite Pharma, Inc.
$42
RECORDATI_RARE_DISEASES_INC.
$36
Aveo Pharmaceuticals, Inc.
$34
ARRAY BIOPHARMA INC
$34
Octapharma USA, Inc.
$26
GlaxoSmithKline, LLC.
$24
PharmaEssentia USA Corporation
$22
Blueprint Medicines Corporation
$20
Apellis Pharmaceuticals, Inc.
$20
Amgen Inc.
$19
Mirati Therapeutics, Inc.
$18
EMD Serono, Inc.
$17
SERVIER PHARMACEUTICALS LLC
$16
Sandoz Inc.
$15
Top 3 companies account for 20.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,407
Genentech USA, Inc.
$1,262
AstraZeneca Pharmaceuticals LP
$1,180
E.R. Squibb & Sons, L.L.C.
$1,076
Amgen Inc.
$906
GENZYME CORPORATION
$731
PFIZER INC.
$691
Celgene Corporation
$621
Lilly USA, LLC
$522
Merck Sharp & Dohme Corporation
$520
Incyte Corporation
$509
Janssen Biotech, Inc.
$490
Daiichi Sankyo Inc.
$453
Eisai Inc.
$438
Merck Sharp & Dohme LLC
$432
Seagen Inc.
$374
JAZZ PHARMACEUTICALS INC.
$342
Janssen Pharmaceuticals, Inc
$333
ABBVIE INC.
$302
Gilead Sciences, Inc.
$293
AMAG Pharmaceuticals, Inc.
$271
BeiGene USA, Inc.
$260
EISAI INC.
$254
Exelixis Inc.
$219
AVEO Pharmaceuticals, Inc.
$218
Alexion Pharmaceuticals, Inc.
$209
Taiho Oncology, Inc.
$209
Astellas Pharma US Inc
$202
Takeda Pharmaceuticals U.S.A., Inc.
$197
Karyopharm Therapeutics Inc.
$183
Boehringer Ingelheim Pharmaceuticals, Inc.
$160
Regeneron Healthcare Solutions, Inc.
$136
Bayer HealthCare Pharmaceuticals Inc.
$128
Dova Pharmaceuticals
$127
Kite Pharma, Inc.
$120
Agios Pharmaceuticals, Inc.
$115
PharmaEssentia USA Corporation
$115
Stemline Therapeutics Inc.
$103
Pharmacosmos Therapeutics Inc.
$100
LeMaitre Vascular, Inc.
$99
SOBI, INC
$96
Jazz Pharmaceuticals Inc.
$90
GlaxoSmithKline, LLC.
$88
ARRAY BIOPHARMA INC
$78
Teva Pharmaceuticals USA, Inc.
$76
RECORDATI_RARE_DISEASES_INC.
$73
TAIHO ONCOLOGY, INC.
$72
EMD Serono, Inc.
$68
Apellis Pharmaceuticals, Inc.
$67
Global Blood Therapeutics, Inc.
$62
Secura Bio, Inc.
$56
Puma Biotechnology, Inc.
$51
SERVIER PHARMACEUTICALS LLC
$50
Organon LLC
$49
Fortovia Therapeutics, Inc.
$48
Aveo Pharmaceuticals, Inc.
$46
G1 Therapeutics, Inc.
$46
Pharmacyclics LLC, An AbbVie Company
$37
Blueprint Medicines Corporation
$36
Ipsen Biopharmaceuticals, Inc
$35
W. L. Gore & Associates, Inc.
$32
TESARO, Inc.
$31
Adaptive Biotechnologies Corporation
$30
MACROGENICS, INC.
$29
Sobi, Inc
$29
Mylan Institutional Inc.
$28
Octapharma USA, Inc.
$26
MorphoSys, US Inc.
$26
AngioDynamics, Inc.
$24
AbbVie Inc.
$20
Deciphera Pharmaceuticals Inc.
$19
Coherus Biosciences Inc.
$19
Endologix LLC
$18
Mirati Therapeutics, Inc.
$18
Sandoz Inc.
$15
Pharmacyclics LLC, an AbbVie Company
$15
INSYS Therapeutics Inc
$14
Alnylam Pharmaceuticals Inc.
$13
Seattle Genetics, Inc.
$12
Mylan Pharmaceuticals Inc.
$12
Top 3 companies account for 21.4% of all-time payments
Associated products mentioned in payments ›
6 · ADAKVEO · AFINITOR · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aliqopa · Alto Abdominal Stent Graft System · Avastin · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CEREZYME · CHANTIX · COSELA · CYRAMZA · Cabometyx · Columvi · Cyclophosphamide · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · ENJAYMO · EVENITY · EXCLUDER Iliac Branch Endoprosthesis · Empaveli · Enhertu · FARYDAK · FASLODEX · FERAHEME · FOTIVDA · Fulphila · GAUCHER-DISEASE · GAZYVA · GILOTRIF · GIVLAARI · Halaven · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · INREBIC · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MARGENZA · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Nplate · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Ogivri · Onivyde · Orserdu · PADCEV · PANZYGA · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PYRUKYND · Padcev · Perjeta · Phesgo · Pomalyst · Prolia · QINLOCK · REBLOZYL · RESTOREFLO · RETEVMO · RYBREVANT · RYDAPT · Revlimid · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · SPRYCEL · SUTENT · SYLVANT · SYNAGIS · SYNDROS · SYNTHROID · Soltamox · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TUKYSA · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · Vanflyta · Vectibix · VenaCure 1470 Pro · Venclexta · Vitrakvi · XALKORI · XARELTO · XPOVIO · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
119
County median income
$76,399
Nearest hospital to ZIP centroid (approximate)
Henry Ford Health Warren Hospital
3.0 mi
3.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kadakol is a mixed practice specialist, with above-average Medicare volume (top 7% in MI), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kadakol experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Kadakol performed 77,010 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Kadakol receive payments from pharmaceutical companies?
Yes. Dr. Kadakol received a total of $17,960 from 80 companies across 1,016 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kadakol's costs compare to other hematology & oncology specialists in Sterling Heights?
Dr. Kadakol's average Medicare payment per service is $2. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kadakol) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Sterling Heights
Browse hematology & oncology specialists in Sterling Heights ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in MI
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in MI
Which MI hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology